Literature DB >> 2177639

Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas.

C Saint-Ruf1, M Gerbault-Seureau, E Viegas-Péquignot, B Zafrani, R Cassingena, B Dutrillaux.   

Abstract

Cytogenetic studies on fresh human breast cancers revealed that homogeneously staining regions (HSRs), which are assumed to represent DNA amplification, are observed in almost half of the cases. To search for a possible relationship between HSRs and proto-oncogene amplification, 16 proto-oncogenes, including ERBB2, were studied by Southern blot analysis in four tumors with two or three HSRs, and in three tumors without HSRs. Only four proto-oncogenes were found to be amplified in at least one tumor each: HST and INT2 (x3), MYC (x2-3), and FES (x greater than 10). The large sizes of the HSRs, which each corresponded to several percent of the haploid genome, were hardly compatible with the low rate of amplification, except for FES and then only if a large adjacent segment was co-amplified. This incomplete correlation was demonstrated by in situ hybridization, using biotinylated probes, which showed fluorescent spots on only one HSR for FES in one tumor and for INT2 in another one. Our results indicate that most of the large amplifications corresponding to HSRs do not involve the proto-oncogenes usually studied in breast cancer. The large amplification of FES, detected in one tumor, may be coincidental.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177639     DOI: 10.1002/gcc.2870020105

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Mammary epithelial hyperplasias: alterations related solely to proliferation?

Authors:  R R Burbano; J B Neto; P M Philbert; C Casartelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

Authors:  A Kallioniemi; O P Kallioniemi; J Piper; M Tanner; T Stokke; L Chen; H S Smith; D Pinkel; J W Gray; F M Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

3.  Sporadic amplification of the insulin receptor gene in human breast cancer.

Authors:  V Papa; G Milazzo; I D Goldfine; F M Waldman; R Vigneri
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

4.  Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.

Authors:  Anita Sathyanarayanan; Hamzeh M Tanha; Divya Mehta; Dale R Nyholt
Journal:  Commun Biol       Date:  2022-06-16

5.  ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

Authors:  O P Kallioniemi; A Kallioniemi; W Kurisu; A Thor; L C Chen; H S Smith; F M Waldman; D Pinkel; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci.

Authors:  M R Teixeira; N Pandis; G Bardi; J A Andersen; N Mandahl; F Mitelman; S Heim
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

7.  Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.

Authors:  J Bernardino; M Gerbault-Seureau; B Zafrani; Y Dericke; E Boudou; H Magdelenat; B Dutrillaux
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.